Pacira Pharmaceuticals, Inc. Reports Third Quarter 2016 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Pacira Pharmaceuticals, Inc. Reports Third Quarter 2016 Financial Results

Pacira Pharma (PCRX) Tops Q3 Views

November 2, 2016 7:35 AM EDT

Pacira Pharma (NASDAQ: PCRX) reported Q3 EPS of $0.22, $0.24 better than the analyst estimate of ($0.02). Revenue for the quarter came in at $68.4 million versus the consensus estimate of $67.16 million.

2016 Outlook

Pacira updates its full year 2016 financial guidance as follows:

EXPAREL net product sales of $263... More